FDA Issues Emergency Use Authorization for First COVID-19 Vaccine
December 12, 2020
Silver Spring, MD – The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.
The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the United States.
FDA issues Emergency Use Authorization for Pfizer-BioNTech COVID-19 Vaccine.
FDA Coronavirus (COVID-19) Update for April 3rd, 2020
April 4, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) continues to play a critical role in accelerating medical countermeasures to treat and prevent Coronavirus (COVID-19).
As part of the response to this pandemic, the agency is taking the lead on a national effort to facilitate the development of, and access to, two investigational therapies derived from human blood.
Coronavirus
